Am J Transplant, Volume 20, Suppl 3 Archives - Page 192 of 223 - ATC Abstracts

2020 American Transplant Congress
Evaluation Of Typical Renal Transplant Infections In Simultaneous Heart-kidney Transplant Recipients
E. J. Henricksen¹, U. Wang¹, R. Lee¹, R. Imai¹, A. Puing², A. Couture², A. Multani³, Y. Moayedi⁴, C. Lenihan⁵, K. K. Khush⁶, J. J. Teuteberg⁵
¹Pharmacy, Stanford Healthcare, Stanford, CA, ²Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, ³Infectious Diseases, UCLA, Los Angeles, CA, ⁴Cardiology, University Health Network, Toronto, ON, Canada, ⁵Department of Medicine, Stanford University, Stanford, CA, ⁶Medicine, Stanford University, Stanford, CA
*Purpose: Simultaneous heart-kidney transplant (SHKT) is an increasingly utilized treatment for patients with end stage heart failure and advanced kidney disease. Data regarding infectious complications…
2020 American Transplant Congress
Everolimus for BKV Nephropathy in Kidney Transplant Recipients: A Prospective, Controlled Study
E. Bussalino¹, D. Bellino¹, L. Marsano¹, F. Massarino¹, R. Russo¹, I. Fontana², G. Zaza³, G. Stallone⁴, E. Paoletti¹
¹Nephrology, Dialysis, and Transplantation, Policlinico San Martino Genova, Genova, Italy, ²Transplantation Unit, Policlinico San Martino Genova, Genova, Italy, ³Renal Unit, Department of Medicine,, University Hospital of Verona, Verona, Italy, ⁴Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
*Purpose: Polyoma BK virus nephropathy (BKVN) of KTRs is associated with adverse outcome, since no specific therapy exists. EVR showed promising antiviral effects but systematic…
2020 American Transplant Congress
Evaluation of the Economic Impact of a New IVD Immunoassay (Immunobiogram) for Immunosuppressive Treatment Adjustment in Kidney Transplant Recipients in Spain
C. Rubio¹, C. Jiménez², M. Crespo³, J. Portolés⁴, D. Rubio¹, T. Diez⁵, I. Portero⁵
¹Health Value, Madrid, Spain, ²La Paz Hospital, Madrid, Spain, ³Consorci Mar Parc de Salut, Barcelona, Spain, ⁴Puerta de Hierro Mahadahonda Hospital, Madrid, Spain, ⁵Biohope Scientific Solutions for Human Health SL, Madrid, Spain
*Purpose: Immunobiogram (IMBG) is a new IVD bioassay developed by Biohope SL with the aim to support clinicians in the personalized adjustment of immunosuppressive therapy…
2020 American Transplant Congress
Validation of Ontario Marginalization Index Generated from 3-Digit Postal Code in Patients with End-Stage Kidney Disease
Q. Wang, N. El-Dassouki, N. D. Edwards, P. Mutia, R. Khairalla, N. Yanga, M. Saqib, A. Ali, H. Ford, A. Dychiao, I. Mucsi
University Health Network, Toronto, ON, Canada
*Purpose: This study validates the 2016 Ontario Marginalization Index (OMI) scores derived from 3-digit postal codes to enable its research use in place of scores…
2020 American Transplant Congress
Improvements in Organ Donation: Riding the Coattails of a National Tragedy
D. Goldberg¹, R. Lynch²
¹Medicine, University of Miami, Miami, FL, ²Emory University, Atlanta, GA
*Purpose: The US organ donation system has received attention from the highest levels of government. It has been debated whether increased donation is attributable solely…
2020 American Transplant Congress
Investigating the 6-Month Effects of the UNOS Allocation System Changes on the Post Transplant Outcomes in Patients with Amyloidosis
P. Banankhah¹, G. Liu¹, J. Nattiv¹, C. Lum², A. Salimbangon³, A. Wolfson⁴, E. DePasquale¹, R. Chand⁵, P. Genyk¹, P. Kingsford¹, J. Li¹, D. Vucicevic⁶, A. Vaidya¹, K. Pandya¹, J. Rahman¹, M. Fong¹, L. Grazette¹, A. Kiankhooy¹, S. Hashmi¹, S. Nuno¹, J. Pizula¹, D. Miklin¹, A. E. Lee¹, K. Yang¹, S. Shah¹
¹Cardiology, University of Southern California, Los Angeles, CA, ²Cardiology, The Queen's Medical Center, Honolulu, HI, ³Cardiology, UCLA Medical Center, Los Angeles, CA, ⁴Cardiology, University of Arizona Sarver Heart Center, Tucson, AZ, ⁵Cardiology, Harbor-UCLA Medical Center, Los Angeles, CA, ⁶Cardiology, Newark Beth-Israel Medical Center, Newark, NJ
*Purpose: Cardiac amyloidosis is an infiltrative cardiomyopathy with poor outcomes. Cardiac transplantation and increased utilization of mechanical support have led to improved outcomes in patients…
2020 American Transplant Congress
Combined Heart-Liver Transplantation: A Systematic Review of the Literature
I. A. Ziogas¹, D. Giannis², P. Kapsampelis², A. Giannopoulou², A. Evangeliou², K. S. Mylonas², G. Tsoulfas³, L. K. Matsuoka¹, M. I. Montenovo¹, M. Izzy¹, S. P. Alexopoulos¹
¹Vanderbilt University Medical Center, Nashville, TN, ²Society of Junior Doctors, Athens, Greece, ³Aristotle University of Thessaloniki, Thessaloniki, Greece
*Purpose: Combined heart-liver transplant (CHLT) has been increasingly utilized as the treatment of choice for candidates with dual end-stage organ disease. We aimed to assess…
2020 American Transplant Congress
Lung Transplantation for Patients with Pneumoconiosis in China: A Multicenter Experience from 2015-2019
J. Zhang¹, D. Liu¹, W. Han², J. Chen¹
¹Lung Transplant Center, Wuxi People's Hospital, Wuxi, China, ²Lung Transplant Center, 1st Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
*Purpose: The pneumoconiosis are parenchymal lung diseases that arise from inhalation of dusts. And lung transplantation is an effective method for the treatment of end-stage…
2020 American Transplant Congress
Epidemiology of Clostridioides Difficile Infection in Intestinal and Multivisceral Transplant Patients at a Single Transplant Center
A. Modi¹, B. Gonzalez², K. Brizendine¹
¹Infectious Disease, Cleveland Clinic, Cleveland, OH, ²Pediatric Infectious Disease, Cleveland Clinic, Cleveland, OH
*Purpose: Solid organ transplant (SOT) recipients face increased risk of Clostridioides difficile infection (CDI), with reported CDI incidence of 7.4%-20% far exceeding that of the…
2020 American Transplant Congress
T Cell Hyporesponsiveness in Kidney Transplant Recipients is Associated with Urinary Tract Infections and Age of Kidney Transplant: Implications for Allograft Nephropathy
A. Assounga, S. Omarjee
Dept of Nephrology, University of KwaZulu-Natal, Durban, South Africa
*Purpose: Chronic allograft nephropathy is the main cause of kidney graft loss. With the use of potent immunosuppressive treatments, acute rejections are less and less…